Universitätsklinikum Essen

The SmartNTx-study: a prospective, randomized controlled trial to investigate additional interventional telemedical management versus standard aftercare in kidney transplant recipients (2025) Schiffer M, Pape L, Wolff JK, Gertges R, Visconti V, Reichert K, Pfau A, et al. Journal article Physical activity and exercise performance in patients after kidney transplantation – Data from the prospective KTx360° aftercare program (2025) Pape L, Boeck HT, Boyen J, Nöhre M, Schiffer L, Kück M, Schieffer E, et al. Journal article Guideline-recommended basic parameter adherence in neurocritical care stroke patients: Observational multicenter individual participant data analysis. (2025) Mrochen A, Alhaj Omar O, Pelz JO, Michalski D, Neugebauer H, Lehrieder D, Knier B, et al. Journal article Gemtuzumab ozogamicin in first-line treatment of CBF-AML: insights from a retrospective multi-center analysis (2025) Ronnacker J, Muller PJ, Mikesch JH, Zukunft S, Weinbergerová B, Šrámek J, Valka J, et al. Journal article [68Ga]Ga-FAPI-46 PET accuracy for cancer imaging with histopathology validation: a single-centre, single-arm, interventional, phase 2 trial (2025) Pabst KM, Weber MM, Laschinsky C, Sandach P, Bartel T, Küper AT, Kessler L, et al. Journal article What are wound coatings? A position paper from the Initiative Chronische Wunden (ICW) e. V. Was sind Wundbeläge? Ein Positionspapier der Initiative Chronische Wunden (ICW) e. V. (2025) Dissemond J, Erfurt-Berge C, Gerber V, Motzkus M, Teubner K, Rembe JD Journal article Final, 10-Year Outcomes with Nivolumab plus Ipilimumab in Advanced Melanoma. (2025) Wolchok JD, Chiarion-Sileni V, Rutkowski P, Cowey CL, Schadendorf D, Wagstaff J, Queirolo P, et al. Journal article Impact of bleeding and thrombosis on outcome of 945 COVID-19 VV-ECMO cases from a German registry (2025) Herrmann J, Schade J, Meybohm P, Paschke N, Hübsch ME, Notz Q, Groene J, et al. Journal article Bispecific antibodies targeting BCMA or GPRC5D are highly effective in relapsed myeloma after CAR T-cell therapy (2024) Merz M, Dima D, Hashmi H, Ahmed N, Stölzel F, Holderried TA, Fenk R, et al. Journal article Corrigendum to “Indirect comparison of capmatinib treatment from GEOMETRY mono-1 trial to SOC in German patients with locally advanced or metastatic NSCLC harboring METex14 skipping mutations” [Eur J Cancer 207 (2024) 114158](S0959804924008141)(10.1016/j.ejca.2024.114158) (2024) Kron A, Scheffler M, Wiesweg M, Hummel HD, Kulhavy J, Gatteloehner S, Kollmeier J, et al. Journal article, Erratum